Discover the key differences between patent exclusivity and market exclusivity in pharma. Learn how USPTO patents and FDA regulatory protections interact to shape drug competition and pricing.
Discover how generic drugs go from FDA approval via the ANDA process to being sold at your local pharmacy, including manufacturing, payer negotiations, and distribution challenges.
An ANDA is the FDA's pathway for approving generic drugs without repeating costly clinical trials. It saves patients billions annually by ensuring safe, effective copies of brand-name medications enter the market quickly.
Generic Drug User Fee Amendments (GDUFA) fund FDA reviews of generic medications, cutting approval times from years to months. Learn how user fees keep generic drugs affordable and accessible.